Outlook Therapeutics News

Outlook Therapeutics | 8-K: Current report

May 28 22:41 ET

Outlook Therapeutics | 10-Q: Quarterly report

May 15 17:22 ET

Outlook Therapeutics | 8-K: Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update

May 15 17:21 ET

Outlook Therapeutics | 8-K: Current report

May 13 16:11 ET

Outlook Therapeutics | EFFECT: Others

May 7 06:09 ET

Outlook Therapeutics | 424B3: Prospectus

May 6 16:15 ET

Outlook Therapeutics | 8-K: Current report

May 1 06:09 ET

Outlook Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 26 16:23 ET

Outlook Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Syntone Ventures LLC(11.4%),Syntone LLC(11.4%), etc.

Apr 17 21:40 ET

Outlook Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Syntone Ventures LLC

Apr 17 20:25 ET

Outlook Therapeutics | D: Filing D

Apr 16 17:26 ET

Outlook Therapeutics | 8-K: Current report

Apr 15 16:55 ET

Outlook Therapeutics | 424B5: Prospectus

Apr 12 16:29 ET

Outlook Therapeutics | 8-K: Current report

Apr 12 16:08 ET

Outlook Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Great Point Partners, LLC(9.99%),Dr. Jeffrey R. Jay, M.D.(9.99%), etc.

Apr 8 16:15 ET

Outlook Therapeutics | EFFECT: Others

Apr 8 06:07 ET

Outlook Therapeutics | CORRESP: CORRESP

Apr 3 22:23 ET

Outlook Therapeutics | UPLOAD: Others

Apr 3 22:17 ET

Outlook Therapeutics | 8-K: Current report

Apr 2 16:23 ET

Outlook Therapeutics | EFFECT: Others

Apr 2 06:09 ET